大鼠脂肪间充质干细胞的分离、培养及其向少突胶质前体细胞的诱导分化

张雅群; Li Fu; 任译延; 乔妍梓; 赵冬梅

doi:10.16098/j.issn.0529-1356.2022.05.003

PDF(2261 KB)

解剖学报 ›› 2022, Vol. 53 ›› Issue (5) : 557-562. DOI: 10.16098/j.issn.0529-1356.2022.05.003

神经生物学

大鼠脂肪间充质干细胞的分离、培养及其向少突胶质前体细胞的诱导分化

张雅群付丽任译延乔妍梓赵冬梅*

作者信息 +

Isolation and culture of rat adipose-derived stem cells and differentiation into oligodendrocyte precursor cells

ZHANG Ya-qun FU Li REN Yi-yan QIAO Yan-zi ZHAO Dong-mei*

Author information +

文章历史 +

摘要

目的改良酶消化法提取脂肪间充质干细胞(ADSCs)，并探讨诱导其分化为少突胶质前体细胞(OPCs)的可行性，为脱髓鞘疾病治疗种子细胞来源提供有效途径。方法取SD大鼠腹股沟区脂肪，Ⅰ型胶原酶和胰蛋白酶联合消化法分离培养ADSCs，Ⅰ型胶原酶组作为对照，细胞计数，观察细胞形态。取第3代细胞，流式细胞术检测细胞的表面标志物CD29、CD90和CD45；成脂诱导，油红O染色；利用干细胞分化培养液及OPCs培养液将ADSCs诱导为OPCs，免疫荧光检测α-N-乙酰基神经氨酸 α-2、8-唾液酸转移酶1（A2B5）、NG2；利用OPCs培养液继续培养OPCs分化为少突胶质细胞(OLs)。结果 Ⅰ型胶原酶组分离的ADSCs为（9.143±0.5084）×10⁷/L，联合酶组为（13.43±0.4809）×10⁷/L，联合酶组较Ⅰ型胶原酶组ADSCs数量多，差异有统计学意义（P＜0.05，n=7）；细胞形态观察显示，ADSCs贴壁生长，呈长梭形；流式细胞术检测CD29 阳性率为99.8%，CD90阳性率为 99.4%，CD45 阳性率为0.35%；成脂诱导后倒置光学显微镜下可见脂滴，油红O染色脂滴呈红染；ADSCs向OPCs诱导第16天，A2B5和NG2表达阳性，A2B5阳性率为（87.03±0.94）%，NG2阳性率为（90.07±0.96）%;继续培养OPCs 3 d，其分化为OLs，髓鞘碱性蛋白（MBP）表达阳性。结论联合酶消化较单独胶原酶消化获取的细胞数量多，分离培养的细胞符合ADSCs的特征，体外可诱导分化为OPCs。

Abstract

Objective To explore the possibility of rat adiposederived stem cells (ADSCs) to differentiate into oligodendrocyte precursor cells(OPCs) and find an effective way to treat demyelinating disease. Methods ADSCs from the inguinal region of SD rats were isolated, digested with collagenase type Ⅰ and trypsin, collagenase type Ⅰ digestion method as control, counted and compared; Cultured in vitro and observed the growth characteristics. After ADSCs subcultured 3 times of passages, CD29, CD90 and CD45 were detected by flow cytometry; After differentiation into adipocyte, the cells were identified by the staining of oil red O; After differentiation into OPCs by stem cell differentiation medium and OPCs induced differentiation medium, the expression of α-N-acetylneuraminic acid α-2, 8-sialyltransferase Ⅰ(A2B5) and NG2 was detected by immunofluorescent staining. Results The number of ADSCs in the combined enzyme group was higher than the collagenase type 1 group (P<0.05, n=7); ADSCs grew in a long shuttle type and their morphology tended to be stable after passage. The surface marker CD29,CD90 were positive, and CD45 was negative. After adipogenic induction, oil red O staining showed red lipid droplets of varying sizes in the cells. After OPCs induction, immunofluorescence detection showed that positive reaction of cell surface fluorescence was seen with antibody to A2B5 and NG2,(87.03±0.94)% expressed A2B5, (90.07±0.96)% expressed NG2. After cultured for 3 days, immunofluorescence detection showed that positive reaction of cell surface fluorescence was seen with antibody to myelin basic protein (MBP). Conclusion ADSCs are obtained by combined enzyme digestion and the cells are much more than collagenase alone and can be induced to OPCs in vitro.

导出引用

张雅群付丽任译延乔妍梓赵冬梅. 大鼠脂肪间充质干细胞的分离、培养及其向少突胶质前体细胞的诱导分化[J]. 解剖学报. 2022, 53(5): 557-562 https://doi.org/10.16098/j.issn.0529-1356.2022.05.003

ZHANG Ya-qun FU Li REN Yi-yan QIAO Yan-zi ZHAO Dong-mei. Isolation and culture of rat adipose-derived stem cells and differentiation into oligodendrocyte precursor cells[J]. Acta Anatomica Sinica. 2022, 53(5): 557-562 https://doi.org/10.16098/j.issn.0529-1356.2022.05.003

中图分类号： R3

参考文献

［1］Berry M, Ahmed Z, Morgan-Warren P, et al. Prospects for mTOR-mediated functional repair after central nervous system trauma［J］. Neurobiol Dis，2016, 85: 99-110.

［2］Luo M, Hu ZhX, Liang DM. Derivation of neuroglia progenitors from human embryonic stem cells in feeder layer-and serum-free medium［J］. Acta Anatomica Sinica, 2011, 42(2): 279-282. (in Chinese)

罗敏，胡智兴，梁道明. 无血清无饲养层人胚胎干细胞向胶质前体细胞的分化［J］. 解剖学报，2011, 42(2): 279-282.

［3］Kirby L, Jin J, Cardona JG, et al. Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination［J］. Nat Commun, 2019, 10(1): 3887.

［4］Zhang P, Kishimoto Y, Grammatikakis I, et al. Senolytic therapy alleviates abeta-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer’s disease model ［J］. Nat Neurosci, 2019, 22(5): 719-728.

［5］Ma H, Wert KJ, Shvartsman D, et al. Establishment of human pluripotent stem cell-derived pancreatic beta-like cells in the mouse pancreas［J］. Proc Natl Acad Sci USA, 2018, 115(15): 3924-3929.

［6］Dietz KC, Polanco JJ, Pol SU, et al. Targeting human oligodendrocyte progenitors for myelin repair ［J］. Exp Neurol, 2016, 283(Pt B): 489-500.

［7］Bacakova L, Zarubova J, Travnickova M, et al. Stem cells: their source, potency and use in regenerative therapies with focus on adipose-derived stem cells-a review［ J］. Biotechnol Adv, 2018, 36(4): 1111-1126.

［8］Ju XJ, Niu YY, Rao LB, et al. Experiment of the differentiation of adipose-derived stem cells into fibroblasts［J］.Acta Anatomica Sinica,2020, 51(4): 513-519. (in Chinese)

鞠晓军，牛友芽，饶利兵，等. 脂肪源性干细胞向成纤维细胞的分化［J］. 解剖学报，2020, 51(4): 513-519.

［9］Barateiro A, Brites D, Fernandes A. Oligodendrocyte development and myelination in neurodevelopment: molecular mechanisms in health and disease［J］. Curr Pharm Des, 2016, 22(6):656-679.

［10］ Hoftberger R, Lassmann H. Inflammatory demyelinating diseases of the central nervous system ［J］. Handb Clin Neurol, 2017, 145: 263-283.

［11］ Plemel JR, Liu WQ, Yong VW. Remyelination therapies: a new direction and challenge in multiple sclerosis ［J］. Nat Rev Drug Discov, 2017, 16(9):617-634.

［12］ Franklin RJM, Ffrench-Constant C. Remyelination in the CNS: from biology to therapy ［J］. Nat Rev Neurosci, 2008, 9(11): 839-855.

［13］ Wang G, Ding L, Gao C, et al. Neuroprotective effect of l-serine against white matter demyelination by harnessing and modulating inflammation in mice ［J］. Neuropharmacology, 2019, 146: 39-49.

［14］ Jkel S, Agirre E, Mendanha Falco A, et al. Altered human oligodendrocyte heterogeneity in multiple sclerosis ［J］. Nature, 2019, 566(7745): 543-547.

［15］ Tokunaga H, Seiwa C, Yoshioka N, et al. An Extract of chinpi, the dried peel of the citrus fruit unshiu, enhances axonal remyelination via promoting the proliferation of oligodendrocyte progenitor cells［J］. Evid Based Complement Alternat Med, 2016, 2016: 8692698.

［16］ Levine JM, Reynolds R, Fawcett JW. The oligodendrocyte precursor cell in health and disease［J］. Trends Neurosci, 2001, 24(1): 39-47.

［17］ Osorio MJ, Goldman SA. Glial progenitor cell-based treatment of the childhood leukodystrophies ［J］. Exp Neurol, 2016, 283(Pt B): 476-488.

［18］ Wang C, Luan Z, Yang Y, et al. High purity of human oligodendrocyte progenitor cells obtained from neural stem cells: suitable for clinical application［J］. J Neurosci Methods, 2015, 240: 61-66.

［19］ Sugaya K, Vaidya M. Stem cell therapies for neurodegenerative diseases ［J］. Adv Exp Med Biol, 2018, 1056: 61-84.

［20］ Fraser J, Wulur I, Alfonso Z, et al. Differences in stem and progenitor cell yield in different subcutaneous adipose tissue depots［J］. Cytotherapy, 2007, 9(5): 459-467.

［21］ Prunet-Marcassus B, Cousin B, Caton D, et al. From heterogeneity to plasticity in adipose tissues: site-specific differences ［J］. Exp Cell Res, 2006, 312(6): 727-736.

［22］ Cheng NC, Lin WJ, Ling TY, et al. Sustained release of adipose-derived stem cells by thermosensitive chitosan/gelatin hydrogel for therapeutic angiogenesis［J］. Acta Biomater, 2017, 51: 258-267.

［23］ Huang Q, Zou Y, Arno MC, et al. Hydrogel scaffolds for differentiation of adipose-derived stem cells［J］. Chem Soc Rev, 2017, 46(20): 6255-6275.

［24］ Ilyasov AA, Milligan CE, Pharr EP, et al. The endocannabinoid system and oligodendrocytes in health and disease ［J］. Front Neurosci, 2018, 12: 733.

［25］ Dimou L, Gallo V. NG2-glia and their functions in the central nervous system［J］. Glia, 2015, 63(8): 1429-1451.